Cowen analyst Ritu Baral is out with a positive research note on shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) after hosting a group meeting last …
Cowen analyst Ritu Baral provides insight on shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) after the biotech company recently posted second-quarter results and offered …
Cowen analyst Ritu Baral was out with a favorable note on shares of Sangamo Biosciences, Inc. (NASDAQ:SGMO), after the biotech company released second-quarter results and provided …
After an investors meeting in New York City this week with ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) touching base about its upcoming commercial launch for Nuplazid, …
Cowen analyst Ritu Baral‘s stance on eteplirsen, Sarepta Therapeutics Inc (NASDAQ:SRPT) pipeline drug for Duchenne Muscular Dystrophy, DMD, is unchanged. This comes after Santhera …
In a research report released Friday, Cowen’s healthcare analyst Ritu Baral shed some light on Sangamo Biosciences, Inc. (NASDAQ:SGMO), after the company announced a restructuring of …
Analysts weighed in on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) with bullish sentiments following the company’s investor meeting this week.
In a research report released Thursday, Cowen analyst Ritu Baral reiterated an Outperform rating on shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) with a price …
In a research report issued today, Cowen analyst Ritu Baral maintained a Market Perform rating on shares of Sarepta Therapeutics Inc. (NASDAQ:SRPT), following …
In a research report issued today, Cowen analyst Ritu Baral maintained an Outperform rating on shares of Mast Therapeutics Inc (NYSEMKT:MSTX), while no price …
